Arkolith/Insider Trading/VTYX/Form 4

Nuss John

CHIEF SCIENTIFIC OFFICERVentyx Biosciences, Inc. (VTYX) · full profile →Form 4 · filed Dec 11, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 10, 2024Option exercise(M)5K$0.20$1K270K
Dec 10, 2024Option exercise(M)194K$0.20$39K464K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 10, 2024Option exercise(M)194K—$00
Dec 10, 2024Option exercise(M)5K—$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-028996) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML